Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:222097rdf:typepubmed:Citationlld:pubmed
pubmed-article:222097lifeskim:mentionsumls-concept:C0019425lld:lifeskim
pubmed-article:222097lifeskim:mentionsumls-concept:C0001627lld:lifeskim
pubmed-article:222097lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:222097lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:222097pubmed:issue1lld:pubmed
pubmed-article:222097pubmed:dateCreated1979-8-29lld:pubmed
pubmed-article:222097pubmed:abstractTextThe increase of plasma cortisol (F), androstenedione (A), 17 alpha-hydroxy-progesterone (17-OH-P) and testosterone (T) was measured after iv administration of ACTH in heterozygotes for CAH and in controls under two different conditions: Test 1: ACTH stimulation was performed without any particular preparation. Test 2: 1.5 mg of dexamethasone (dex.) was given the evening before the ACTH stimulation. Plasma F, A, 17-OH-P and T were measured by specific radioimmunoassays (RIA). Following ACTH stimulation, the increase of 17-OH-P was significantly higher in CAH-heterozygotes than in controls in both tests (P less than 0.0005). Heterozygotes were characterized by a 17-OH-P increase after ACTH stimulation exceeding the + 2 SD limit of the 17-OH-P increase found in controls. The detection of female heterozygotes was considerably improved by the administration of dex. before testing (test 2). In males, however, a better identification of heterozygotes was obtained without previous administration of dex. (test 1). By these tests, 100% of female (test 2) and 79% of male (test 1) CAH heterozygotes could be correctly identified. There were no significant differences in the levels of F, A and T between heterozygotes and controls except for decreased T levels in test 1 (2P less than 0.01) in most male heterozygotes after ACTH stimulation.lld:pubmed
pubmed-article:222097pubmed:languageenglld:pubmed
pubmed-article:222097pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:222097pubmed:citationSubsetIMlld:pubmed
pubmed-article:222097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:222097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:222097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:222097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:222097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:222097pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:222097pubmed:statusMEDLINElld:pubmed
pubmed-article:222097pubmed:monthMaylld:pubmed
pubmed-article:222097pubmed:issn0001-5598lld:pubmed
pubmed-article:222097pubmed:authorpubmed-author:ButenandtOOlld:pubmed
pubmed-article:222097pubmed:authorpubmed-author:KnorrDDlld:pubmed
pubmed-article:222097pubmed:authorpubmed-author:WeilJJlld:pubmed
pubmed-article:222097pubmed:authorpubmed-author:BidlingmaierF...lld:pubmed
pubmed-article:222097pubmed:authorpubmed-author:SippellW GWGlld:pubmed
pubmed-article:222097pubmed:issnTypePrintlld:pubmed
pubmed-article:222097pubmed:volume91lld:pubmed
pubmed-article:222097pubmed:ownerNLMlld:pubmed
pubmed-article:222097pubmed:authorsCompleteYlld:pubmed
pubmed-article:222097pubmed:pagination109-21lld:pubmed
pubmed-article:222097pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-H...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-E...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-T...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-F...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-M...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-A...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-A...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-H...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-A...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-D...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-H...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-A...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-P...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-H...lld:pubmed
pubmed-article:222097pubmed:meshHeadingpubmed-meshheading:222097-A...lld:pubmed
pubmed-article:222097pubmed:year1979lld:pubmed
pubmed-article:222097pubmed:articleTitleComparison of two tests for heterozygosity in congenital adrenal hyperplasia (CAH).lld:pubmed
pubmed-article:222097pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:222097pubmed:publicationTypeComparative Studylld:pubmed